These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 9040115)

  • 21. Opioids in chronic pain.
    Przewłocki R; Przewłocka B
    Eur J Pharmacol; 2001 Oct; 429(1-3):79-91. PubMed ID: 11698029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics of alcoholism: role of the endogenous opioid system.
    Gianoulakis C; de Waele JP
    Metab Brain Dis; 1994 Jun; 9(2):105-31. PubMed ID: 8072460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of endogenous beta-endorphin and enkephalins in ethanol reward.
    Tseng A; Nguyen K; Hamid A; Garg M; Marquez P; Lutfy K
    Neuropharmacology; 2013 Oct; 73():290-300. PubMed ID: 23770261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of opioid-dopamine interactions in the induction and maintenance of ethanol consumption.
    Cowen MS; Lawrence AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Oct; 23(7):1171-212. PubMed ID: 10581642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of endogenous opioids and dopamine in alcoholism: human and basic science studies.
    Gianoulakis C
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():33-42. PubMed ID: 8736999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the opioid system in selected brain regions of alcohol-preferring and alcohol-nonpreferring rats.
    Fadda P; Tronci S; Colombo G; Fratta W
    Alcohol Clin Exp Res; 1999 Aug; 23(8):1296-305. PubMed ID: 10470971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sigma receptor-induced heavy drinking in rats: Modulation by the opioid receptor system.
    Valenza M; Blasio A; DiLeo A; Cottone P; Sabino V
    Pharmacol Biochem Behav; 2020 May; 192():172914. PubMed ID: 32205151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delta-opioid receptor antagonism leads to excessive ethanol consumption in mice with enhanced activity of the endogenous opioid system.
    Poznanski P; Lesniak A; Korostynski M; Szklarczyk K; Lazarczyk M; Religa P; Bujalska-Zadrozny M; Sadowski B; Sacharczuk M
    Neuropharmacology; 2017 May; 118():90-101. PubMed ID: 28322978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid reward and aversion effects in the posterior ventral tegmental area are mediated through dissociable opiate receptor subtypes and separate amygdalar and accumbal dopamine receptor substrates.
    Ahmad T; Laviolette SR
    Psychopharmacology (Berl); 2017 Aug; 234(15):2325-2336. PubMed ID: 28669034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethanol as a neurochemical surrogate of conventional reinforcers: the dopamine-opioid link.
    Di Chiara G; Acquas E; Tanda G
    Alcohol; 1996; 13(1):13-7. PubMed ID: 8837928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal ethanol exposure and enkephalinergic neurotransmission.
    Méndez M; Hernández-Fonseca K; Abate P
    Vitam Horm; 2019; 111():313-337. PubMed ID: 31421706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accumbal μ-Opioid Receptors Modulate Ethanol Intake in Alcohol-Preferring Alko Alcohol Rats.
    Uhari-Väänänen J; Raasmaja A; Bäckström P; Oinio V; Airavaara M; Piepponen P; Kiianmaa K
    Alcohol Clin Exp Res; 2016 Oct; 40(10):2114-2123. PubMed ID: 27508965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The μ-opioid receptor and treatment response to naltrexone.
    Thorsell A
    Alcohol Alcohol; 2013; 48(4):402-8. PubMed ID: 23543091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The opioidergic-alcohol link : implications for treatment.
    Modesto-Lowe V; Fritz EM
    CNS Drugs; 2005; 19(8):693-707. PubMed ID: 16097851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking.
    Hyytiä P; Ingman K; Soini SL; Laitinen JT; Korpi ER
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):391-401. PubMed ID: 10551276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain regional Fos expression elicited by the activation of mu- but not delta-opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward.
    David V; Matifas A; Gavello-Baudy S; Decorte L; Kieffer BL; Cazala P
    Neuropsychopharmacology; 2008 Jun; 33(7):1746-59. PubMed ID: 17895918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
    Walker BM; Koob GF
    Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous delivery of naltrexone and nalmefene leads to tolerance in reducing alcohol drinking and to supersensitivity of brain opioid receptors.
    Korpi ER; Linden AM; Hytönen HR; Paasikoski N; Vashchinkina E; Dudek M; Herr DR; Hyytiä P
    Addict Biol; 2017 Jul; 22(4):1022-1035. PubMed ID: 26990998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opiates and alcohol self-administration in animals.
    Ulm RR; Volpicelli JR; Volpicelli LA
    J Clin Psychiatry; 1995; 56 Suppl 7():5-14. PubMed ID: 7673105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.